{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:42:54Z","timestamp":1751715774795,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,20]]},"DOI":"10.7759\/cureus.79341","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:27:24Z","timestamp":1740040044000},"source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori in Bahrain: A Comprehensive Study of Patient Characteristics, Treatment Approaches, and Cure Rates"],"prefix":"10.7759","author":[{"given":"Mahmood","family":"Alawainati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtadha M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"AlShaalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husain I","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasim M","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiya","family":"Almusawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.112288","article-title":"Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease","volume":"5","author":"Mhaskar RS","year":"2013","unstructured":"Mhaskar RS, Ricardo I, Azliyati A, Laxminarayan R, Amol B, Santosh W, Boo K. Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease. J Glob Infect Dis. 2013, 5:60-7. 10.4103\/0974-777X.112288","journal-title":"J Glob Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner P","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, et al.. Helicobacter pylori infection. Nat Rev Dis Primers. 2023, 9:19. 10.1038\/s41572-023-00431-8","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","article-title":"H. pylori infection: ACG updates treatment recommendations","volume":"97","author":"Randel A","year":"2018","unstructured":"Randel A. H. pylori infection: ACG updates treatment recommendations. Am Fam Physician. 2018, 97:135-7.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18999\/nagjms.84.2.374","article-title":"Impact of socioeconomic status and sibling number on the prevalence of Helicobacter pylori infection: a cross-sectional study in a Japanese population","volume":"84","author":"Elshair M","year":"2022","unstructured":"Elshair M, Ugai T, Oze I, et al.. Impact of socioeconomic status and sibling number on the prevalence of Helicobacter pylori infection: a cross-sectional study in a Japanese population. Nagoya J Med Sci. 2022, 84:374-87. 10.18999\/nagjms.84.2.374","journal-title":"Nagoya J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2019_357","article-title":"Epidemiology, diagnosis and risk factors of Helicobacter pylori infection","volume":"1149","author":"Kotilea K","year":"2019","unstructured":"Kotilea K, Bontems P, Touati E. Epidemiology, diagnosis and risk factors of Helicobacter pylori infection. Adv Exp Med Biol. 2019, 1149:17-33. 10.1007\/5584_2019_357","journal-title":"Adv Exp Med Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2017.0144","article-title":"A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer","volume":"30","author":"Rokkas T","year":"2017","unstructured":"Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol. 2017, 30:414-23. 10.20524\/aog.2017.0144","journal-title":"Ann Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211014087","article-title":"Treatment approach of refractory Helicobacter pylori infection: a comprehensive review","volume":"12","author":"Cort\u00e9s P","year":"2021","unstructured":"Cort\u00e9s P, Nelson AD, Bi Y, et al.. Treatment approach of refractory Helicobacter pylori infection: a comprehensive review. J Prim Care Community Health. 2021, 12:10.1177\/21501327211014087","journal-title":"J Prim Care Community Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-022-01322-8","article-title":"Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: a randomized controlled trial","volume":"42","author":"Panigrahi MK","year":"2023","unstructured":"Panigrahi MK, Chouhan MI, Hallur VK, et al.. Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: a randomized controlled trial. Indian J Gastroenterol. 2023, 42:517-24. 10.1007\/s12664-022-01322-8","journal-title":"Indian J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13020136","article-title":"Sequential versus standard triple therapy for first-line helicobacter pylori eradication: an update","volume":"13","author":"Nyssen OP","year":"2024","unstructured":"Nyssen OP, Mart\u00ednez B, M\u00e9graud F, Savarino V, Fallone CA, Bazzoli F, Gisbert JP. Sequential versus standard triple therapy for first-line helicobacter pylori eradication: an update. Antibiotics (Basel). 2024, 13:10.3390\/antibiotics13020136","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.04.012","article-title":"Comparative effectiveness of multiple different first-line treatment regimens for helicobacter pylori infection: a network meta-analysis","volume":"161","author":"Rokkas T","year":"2021","unstructured":"Rokkas T, Gisbert JP, Malfertheiner P, et al.. Comparative effectiveness of multiple different first-line treatment regimens for helicobacter pylori infection: a network meta-analysis. Gastroenterology. 2021, 161:495-507. 10.1053\/j.gastro.2021.04.012","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311868","article-title":"First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis","volume":"67","author":"Yeo YH","year":"2018","unstructured":"Yeo YH, Shiu SI, Ho HJ, et al.. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. Gut. 2018, 67:20-7. 10.1136\/gutjnl-2016-311868","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey WD","year":"2024","unstructured":"Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024, 119:1730-53. 10.14309\/ajg.0000000000002968","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong TC","year":"2024","unstructured":"Hong TC, El-Omar EM, Kuo YT, et al.. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024, 9:56-67. 10.1016\/S2468-1253(23)00281-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13103","article-title":"Global primary antibiotic resistance rate of Helicobacter pylori in recent 10\u2009years: a systematic review and meta-analysis","volume":"29","author":"Yu Y","year":"2024","unstructured":"Yu Y, Xue J, Lin F, Liu D, Zhang W, Ru S, Jiang F. Global primary antibiotic resistance rate of Helicobacter pylori in recent 10\u2009years: a systematic review and meta-analysis. Helicobacter. 2024, 29:e13103. 10.1111\/hel.13103","journal-title":"Helicobacter"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_288_22","article-title":"Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations","volume":"29","author":"Alsohaibani F","year":"2023","unstructured":"Alsohaibani F, Peedikayil M, Alshahrani A, Somily A, Alsulaiman R, Azzam N, Almadi M. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi J Gastroenterol. 2023, 29:326-46. 10.4103\/sjg.sjg_288_22","journal-title":"Saudi J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i32.4846","article-title":"Current status of Helicobacter pylori eradication and risk factors for eradication failure","volume":"26","author":"Yan TL","year":"2020","unstructured":"Yan TL, Gao JG, Wang JH, Chen D, Lu C, Xu CF. Current status of Helicobacter pylori eradication and risk factors for eradication failure. World J Gastroenterol. 2020, 26:4846-56. 10.3748\/wjg.v26.i32.4846","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70044","article-title":"Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: a subgroup analysis of the pHalcon-HP trial","volume":"8","author":"Chey WD","year":"2024","unstructured":"Chey WD, M\u00e9graud F, Laine L, Smith N, Leifke E, Hunt B, Howden CW. Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: a subgroup analysis of the pHalcon-HP trial. JGH Open. 2024, 8:e70044. 10.1002\/jgh3.70044","journal-title":"JGH Open"},{"key":"ref18","article-title":"Antibiotic susceptibilities of Helicobacter pylori","volume":"22","author":"Bindayna KM","year":"2001","unstructured":"Bindayna KM. Antibiotic susceptibilities of Helicobacter pylori. Saudi Med J. 2001, 22:53-7.","journal-title":"Saudi Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_398_19","article-title":"Prevalence and patient characteristics of Helicobacter pylori among adult in primary health care of security forces hospital Riyadh, Saudi Arabia, 2018","volume":"8","author":"Alharbi RH","year":"2019","unstructured":"Alharbi RH, Ghoraba M. Prevalence and patient characteristics of Helicobacter pylori among adult in primary health care of security forces hospital Riyadh, Saudi Arabia, 2018. J Family Med Prim Care. 2019, 8:2202-6. 10.4103\/jfmpc.jfmpc_398_19","journal-title":"J Family Med Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279396","article-title":"Helicobacter pylori infection and its associated factors among dyspepsia patients attending Debre Tabor Comprehensive Specialized Hospital, 2020","volume":"18","author":"Jemere T","year":"2023","unstructured":"Jemere T, Tilahun M, Walle G, et al.. Helicobacter pylori infection and its associated factors among dyspepsia patients attending Debre Tabor Comprehensive Specialized Hospital, 2020. PLoS One. 2023, 18:e0279396. 10.1371\/journal.pone.0279396","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/children9091359","article-title":"Worldwide prevalence and risk factors of Helicobacter pylori infection in children","volume":"9","author":"Borka Balas R","year":"2022","unstructured":"Borka Balas R, Meli\u021b LE, M\u0103rginean CO. Worldwide prevalence and risk factors of Helicobacter pylori infection in children. Children (Basel). 2022, 9:10.3390\/children9091359","journal-title":"Children (Basel)"},{"key":"ref22","article-title":"Female gender and Helicobacter pylori infection, the most important predisposition factors in a cohort of gastric cancer: a longitudinal study","volume":"7","author":"Agah S","year":"2016","unstructured":"Agah S, Khedmat H, Ghamar-Chehred ME, Hadi R, Aghaei A. Female gender and Helicobacter pylori infection, the most important predisposition factors in a cohort of gastric cancer: a longitudinal study. Caspian J Intern Med. 2016, 7:136-41.","journal-title":"Caspian J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700268","article-title":"The prevalence of helicobacter pylori and gastritis in Oman","volume":"4","author":"Alwahaibi NY","year":"2013","unstructured":"Alwahaibi NY, Almahrooqi BM, Alrawahi SA. The prevalence of helicobacter pylori and gastritis in Oman. J Dig Endosc. 2013, 4:029-32. 10.1055\/s-0039-1700268","journal-title":"J Dig Endosc"},{"key":"ref24","article-title":"Original article prevalence and diagnosis of Helicobacter pylori infection in a tertiary hospital in the Kingdom of Bahrain","volume":"43","author":"Alshaikh S","year":"2021","unstructured":"Alshaikh S, Al Sharakhat A, Toorani Z, Farid E, Abdulla M. Original article prevalence and diagnosis of Helicobacter pylori infection in a tertiary hospital in the Kingdom of Bahrain. BMB. 2021, 43:547-50.","journal-title":"BMB"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.03.019","article-title":"Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies","volume":"49","author":"Ibrahim A","year":"2017","unstructured":"Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Dig Liver Dis. 2017, 49:742-9. 10.1016\/j.dld.2017.03.019","journal-title":"Dig Liver Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221125308","article-title":"Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis","volume":"15","author":"Wang Z","year":"2022","unstructured":"Wang Z, Wang F. Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2022, 15:10.1177\/17562848221125308","journal-title":"Therap Adv Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02707-5","article-title":"Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis","volume":"23","author":"Fekadu S","year":"2023","unstructured":"Fekadu S, Engiso H, Seyfe S, Iizasa H, Godebo A, Deyno S, Yoshiyama H. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis. BMC Gastroenterol. 2023, 23:55. 10.1186\/s12876-023-02707-5","journal-title":"BMC Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_719_19","article-title":"A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection","volume":"52","author":"Mokhtare M","year":"2020","unstructured":"Mokhtare M, Nikkhah M, Behnam B, Agah S, Bahardoust M, Masoodi M, Faghihi A. A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection. Indian J Pharmacol. 2020, 52:266-71. 10.4103\/ijp.IJP_719_19","journal-title":"Indian J Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13030211","article-title":"Predictors of successful first-line Helicobacter pylori eradication with fluoroquinolones in Pakistan: a prospective exploration of demographic and clinical factors","volume":"13","author":"Khadim S","year":"2024","unstructured":"Khadim S, Muhammad IN, Alam T, Usman S, Rehman H, Haider S. Predictors of successful first-line Helicobacter pylori eradication with fluoroquinolones in Pakistan: a prospective exploration of demographic and clinical factors. Antibiotics (Basel). 2024, 13:10.3390\/antibiotics13030211","journal-title":"Antibiotics (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-024-00618-8","article-title":"Prevalence of Helicobacter pylori infection and effectiveness of first-line triple eradication therapy among dyspeptic patients at hospitals in Hawassa City, Ethiopia: a cross-sectional follow-up study","volume":"16","author":"Fekadu S","year":"2024","unstructured":"Fekadu S, Kibru S, Tesfaye S, Egeno T, Tamiso A, Engiso H, Deyno S. Prevalence of Helicobacter pylori infection and effectiveness of first-line triple eradication therapy among dyspeptic patients at hospitals in Hawassa City, Ethiopia: a cross-sectional follow-up study. Gut Pathog. 2024, 16:23. 10.1186\/s13099-024-00618-8","journal-title":"Gut Pathog"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337576-helicobacter-pylori-in-bahrain-a-comprehensive-study-of-patient-characteristics-treatment-approaches-and-cure-rates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:27:27Z","timestamp":1740040047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337576-helicobacter-pylori-in-bahrain-a-comprehensive-study-of-patient-characteristics-treatment-approaches-and-cure-rates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.79341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}